<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04938414</url>
  </required_header>
  <id_info>
    <org_study_id>2020-892</org_study_id>
    <nct_id>NCT04938414</nct_id>
  </id_info>
  <brief_title>Investigate the Relationship Between Inflammatory and Coagulation in SAH CSF</brief_title>
  <official_title>Inhibition of Caspase-1 Reduces Pyroptotic Neuroinflammation and Tissue Factor-Induced Cerebrospinal Fluid Circulation Impairment After Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the role of inflammasome and blood coagulation response in human cerebrospinal&#xD;
      fluid after subarachnoid hemorrhage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigate the role of inflammasome and blood coagulation response in human cerebrospinal&#xD;
      fluid after subarachnoid hemorrhage (SAH).&#xD;
&#xD;
      1.40 patients with SAH will be included. The CSF will used for ELISA test for inflammatory&#xD;
      factors and cogulation factors.&#xD;
&#xD;
      2.CSF obtained from 4 patients with non-neuroloogical disease with 4 addittional SAH patients&#xD;
      will be used for Mass Spectrometry&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>evaluated 1day after discharge</time_frame>
    <description>Length of hospital stay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>evaluated 1day after discharge</time_frame>
    <description>modified Rankin Scale at discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glasgow Outcome Scale</measure>
    <time_frame>evaluated 1day after discharge</time_frame>
    <description>Glasgow Outcome Scale at discharge</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <arm_group>
    <arm_group_label>subarachnoid hemorrhage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with subarachnoid hemorrhage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with non-neurological diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lumbar puncture</intervention_name>
    <description>Lumbar puncture to obtain the cerebrospinal fluid and for diagnostic test</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>subarachnoid hemorrhage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  SAH patients with modified Fisher Scale 3-4.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of CNS disease (e.g., stroke, traumatic brain injury, CNS&#xD;
             infection) or accompanied by serious comorbidities before SAH onset (e.g., severe&#xD;
             coagulation disorders, malignant tumor, uncontrollable heart disease, and&#xD;
             hypertension) or other organ dysfunctions within 6 months were excluded from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuanjian Fang, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Zhejiang Univerisity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Second affiliated hosipital of zhejiang univerisity school of medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2021</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>subarachnoid hemorrhage</keyword>
  <keyword>coagulation</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

